EN
中
HOME
OUR COMPANY
About Us
History
Leadership
Awards
PLATFORM
Formulation platform
Device platform
R&D
Pipeline
MEDIA
News center
Publications
INVESTORS
Our Investors
CONTACT US
Join Us
Our Office
OUR INVESTORS
RMB80 million Series B closed in September 2020 from high quality investors including:
KAITAI CAPITAL
DELIAN CAPITAL
Shenzhen Guozhong Venture Capital Management
YIPNHONG PHARMACY
BOC & UTRUST PEFM
